Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
A new Class I recall | The first type 1 diabetes treatment of its kind | VR during TAVR | More from the last week
Saturday, July 1, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

FDA announces recall of more than 250,000 interventional devices due to risk of catheter separation

The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of more than 250,000 interventional devices due to risk of catheter separation

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far. 
READ MORE >

FDA approves first cellular therapy to treat type 1 diabetes

The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin. 

READ MORE >
The FDA has approved donislecel, a new pancreatic islet cellular therapy made from the pancreatic cells of deceased donors, for the treatment of type 1 diabetes among adult patients with severe hypoglycemia. Lantidra
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first cellular therapy to treat type 1 diabetes

Share on Twitter Share on Facebook Share on Linkedin
The FDA has approved donislecel, a new pancreatic islet cellular therapy made from the pancreatic cells of deceased donors, for the treatment of type 1 diabetes among adult patients with severe hypoglycemia. Lantidra
The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin. 
READ MORE >

Balloon-expandable valves deliver better short-term TAVR outcomes than self-expandable valves

A new meta-analysis, published in Frontiers in Cardiovascular Medicine, focused on data from nearly 3,000 patients with severe symptomatic aortic stenosis.

READ MORE >
The Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device in a heart model used to show patients how the device works.
Share on Twitter Share on Facebook Share on Linkedin

Balloon-expandable valves deliver better short-term TAVR outcomes than self-expandable valves

Share on Twitter Share on Facebook Share on Linkedin
The Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device in a heart model used to show patients how the device works.
A new meta-analysis, published in Frontiers in Cardiovascular Medicine, focused on data from nearly 3,000 patients with severe symptomatic aortic stenosis.
READ MORE >

Cardiologists applaud FDA’s approval of colchicine for CVD

"The FDA's approval of colchicine confirms that we are entering a new era of patient care," said one veteran cardiologist familiar with the drug. 

READ MORE >
The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment. Colchicine prevents coronary artery plaque inflammation, heart inflammation. Colchicine for coronary artery disease. Colchicine for coronary inflammation FDA Approves Colchicine for Decreasing CV Events FDA Approves Colchicine for decreasing inflammation caused by coronary atherosclerosis.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists applaud FDA’s approval of colchicine for CVD

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment. Colchicine prevents coronary artery plaque inflammation, heart inflammation. Colchicine for coronary artery disease. Colchicine for coronary inflammation FDA Approves Colchicine for Decreasing CV Events FDA Approves Colchicine for decreasing inflammation caused by coronary atherosclerosis.
"The FDA's approval of colchicine confirms that we are entering a new era of patient care," said one veteran cardiologist familiar with the drug. 
READ MORE >

Cardiology at the supermarket: Shopping carts upgraded to detect signs of AFib

Attaching ECG sensors to the handles of shopping carts could help identify signs of atrial fibrillation in patients who don't even realize they have it. 

READ MORE >
Shopping Cart ECG electrocardiogram AFib atrial fibrillation
Share on Twitter Share on Facebook Share on Linkedin

Cardiology at the supermarket: Shopping carts upgraded to detect signs of AFib

Share on Twitter Share on Facebook Share on Linkedin
Shopping Cart ECG electrocardiogram AFib atrial fibrillation
Attaching ECG sensors to the handles of shopping carts could help identify signs of atrial fibrillation in patients who don't even realize they have it. 
READ MORE >

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD

“Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible,” an executive with Agepha Pharma told Cardiovascular Business. 

READ MORE >
Colchicine Lodoco Agepha Pharma price cost cardiovascular disease CVD
Share on Twitter Share on Facebook Share on Linkedin

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD

Share on Twitter Share on Facebook Share on Linkedin
Colchicine Lodoco Agepha Pharma price cost cardiovascular disease CVD
“Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible,” an executive with Agepha Pharma told Cardiovascular Business. 
READ MORE >

Cardiologists earn the highest annual salary in 2 states

According to new data out of the U.S. Department of Labor, physicians have the highest-paying jobs in a majority of states. Cardiologists specifically rank No. 1 in two different states. 

READ MORE >
cardiologist patient heart compensation starting salary 2022 interventional cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists earn the highest annual salary in 2 states

Share on Twitter Share on Facebook Share on Linkedin
cardiologist patient heart compensation starting salary 2022 interventional cardiologist
According to new data out of the U.S. Department of Labor, physicians have the highest-paying jobs in a majority of states. Cardiologists specifically rank No. 1 in two different states. 
READ MORE >

Virtual reality during TAVR: Distracting patients linked to key benefits

When patients wear VR glasses during transcatheter aortic valve replacement, they say it helps time go by more quickly and reduces anxiety.

READ MORE >
elderly patient using virtual reality TAVR transcatheter aortic valve replacement
Share on Twitter Share on Facebook Share on Linkedin

Virtual reality during TAVR: Distracting patients linked to key benefits

Share on Twitter Share on Facebook Share on Linkedin
elderly patient using virtual reality TAVR transcatheter aortic valve replacement
When patients wear VR glasses during transcatheter aortic valve replacement, they say it helps time go by more quickly and reduces anxiety.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup